Title:
ANTIGEN BINDING PROTEINS
Document Type and Number:
WIPO Patent Application WO/2021/058711
Kind Code:
A3
Abstract:
The present disclosure relates to compositions for treating CD96 mediated diseases, and related methods.
Inventors:
DEGENHARDT YAN Y (US)
GUAN JUN (US)
HANCE KENNETH WILLIAM (US)
MORLEY PETER JOSEPH (GB)
GUAN JUN (US)
HANCE KENNETH WILLIAM (US)
MORLEY PETER JOSEPH (GB)
Application Number:
PCT/EP2020/076834
Publication Date:
June 03, 2021
Filing Date:
September 25, 2020
Export Citation:
Assignee:
GLAXOSMITHKLINE IP DEV LTD (GB)
International Classes:
C07K16/28; A61P35/00; A61K39/00
Domestic Patent References:
| WO2019030377A1 | 2019-02-14 |
Other References:
S. J. BLAKE ET AL: "Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy", CLINICAL CANCER RESEARCH, vol. 22, no. 21, 1 November 2016 (2016-11-01), US, pages 5183 - 5188, XP055419815, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-16-0933
Attorney, Agent or Firm:
KUCERNAK, Lynn (GB)
Download PDF: